 |
市場調查報告書
商品編碼
1902665
心臟移植市場規模、佔有率和成長分析（按類型、最終用戶和地區分類）—2026-2033年產業預測Heart Transplant Market Size, Share, and Growth Analysis, By Type (Ventricular Assist Devices, Total Artificial Hearts), By End User (Hospitals, Cardiac Institutes), By Region - Industry Forecast 2026-2033 |
||||||
預計到 2024 年，全球心臟移植市場規模將達到 128.2 億美元，到 2025 年將達到 141.6 億美元，到 2033 年將達到 314.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 10.5%。
全球心臟移植市場為我們深入了解器官移植的發展趨勢提供了重要視野。末期心臟病盛行率的不斷上升，顯著推動了心臟移植這項至關重要的救命療法的需求。外科手術技術、免疫抑制療法和器官保存方法的創新，大大促進了市場的擴張。然而，供體心臟的持續短缺構成了一項重大挑戰，凸顯了加強器官籌資策略和拓寬移植標準的必要性。此外，醫學界的持續研究與合作在改善患者預後和解決心臟移植相關複雜挑戰方面發揮關鍵作用。總而言之，這些因素正在塑造心臟移植市場的未來，並凸顯了適應和創新的重要性。
全球心臟移植市場促進因素
全球心臟移植市場面臨的一大挑戰是捐贈器官（尤其是可移植心臟）持續短缺，這限制了可進行的移植手術數量。這種短缺不僅阻礙了病患獲得挽救生命的移植手術，也給醫療系統帶來了沉重的負擔。此外，器官取得、儲存和運輸的複雜物流流程也增加了難度，使心臟移植手術的成功率進一步降低。這些因素造成了市場瓶頸，亟需創新解決方案來增加器官供應並簡化移植相關流程。
限制全球心臟移植市場的因素
全球心臟移植市場面臨的一大挑戰是捐贈器官（尤其是可移植心臟）的長期短缺，這限制了可進行的移植手術數量。這種短缺阻礙了患者獲得挽救生命的手術。此外，器官的取得、儲存和運輸涉及複雜的物流環節，也帶來了進一步的挑戰，阻礙了移植計畫的有效運作。這些因素共同作用，阻礙了整個心臟移植市場的成長和效率，因為醫療機構在嚴格的營運要求下，難以平衡供需關係。
全球心臟移植市場趨勢
全球心臟移植市場正經歷顯著的轉型，朝著能夠改善器官保存和移植效果的先進技術邁進。常溫機械灌注等創新技術正在提高捐贈心臟的存活率，而用於個人化醫療的基因檢測也正蓬勃發展。同時，再生醫學，特別是幹細胞療法，正被研究用於降低排斥風險和促進復原。此外，遠端醫療和遠端患者監護的廣泛應用正在改變移植後的護理模式，實現對患者健康的持續管理。最尖端科技、個人化治療和完善的術後支持相結合，凸顯了心臟移植領域的蓬勃發展。
目錄
介紹
- 調查目標
- 調查範圍
- 定義
調查方法
- 資訊收集
- 二手資料和一手資料方法
- 市場規模預測
- 市場假設與限制
執行摘要
- 全球市場展望
- 供需趨勢分析
- 細分市場機會分析
市場動態與展望
- 市場規模
- 市場動態
- 促進因素和機遇
- 限制與挑戰
- 波特分析
關鍵市場考察
- 關鍵成功因素
- 競爭程度
- 關鍵投資機會
- 市場生態系統
- 市場吸引力指數（2025）
- PESTEL 分析
- 總體經濟指標
- 價值鏈分析
- 定價分析
- 監管環境
- 案例研究
- 技術進步
全球心臟移植市場規模（按類型及複合年成長率分類）（2026-2033 年）
- 心室輔助裝置
- 全人工心臟
- 其他
全球心臟移植市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）
- 醫院
- 心臟研究所
- 其他
全球心臟移植市場規模及複合年成長率（2026-2033）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區
競爭資訊
- 前五大公司對比
- 主要企業的市場定位（2025 年）
- 主要市場參與者所採取的策略
- 近期市場趨勢
- 公司市佔率分析（2025 年）
- 主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- Optum Inc.（USA）
- Novartis Pharmaceuticals UK Ltd.（UK）
- Abbott Laboratories（USA）
- Medtronic PLC（Ireland）
- Stryker Corporation（USA）
- Roche Diagnostics Ltd.（Switzerland）
- Mayo Clinic（USA）
- Cleveland Clinic（USA）
- AstraZeneca PLC（UK）
- Massachusetts General Hospital（USA）
- Terumo Corp.（Japan）
- NewYork-Presbyterian Hospital（USA）
- Cedars-Sinai Medical Center（USA）
- Maquet Holding BV and Co. KG.（Germany）
- Teleflex Inc.（USA）
- Stanford Health Care（USA）
- Johns Hopkins Hospital（USA）
- Thoratec Corporation（USA）
- Abiomed Inc.（USA）
- Baylor St. Luke's Medical Center（USA）
結論與建議
Global Heart Transplant Market size was valued at USD 12.82 Billion in 2024 and is poised to grow from USD 14.16 Billion in 2025 to USD 31.48 Billion by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).
The global heart transplant market reveals critical insights into organ transplantation dynamics. The rising prevalence of end-stage heart diseases significantly fuels the demand for heart transplants as essential life-saving solutions. Innovations in surgical techniques, immunosuppressive therapies, and organ preservation methods significantly contribute to market expansion. However, a persistent shortage of donor hearts presents a considerable challenge, highlighting the need for enhanced organ procurement strategies and broader transplantation criteria. Moreover, ongoing research initiatives and collaborations within the medical community play a crucial role in improving patient outcomes and tackling the complex issues associated with heart transplantation. Collectively, these factors shape the future landscape of the heart transplant market, underscoring the importance of adaptation and innovation.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Heart Transplant Market Segments Analysis
Global Heart Transplant Market is segmented by Type, End User and region. Based on Type, the market is segmented into Ventricular Assist Devices, Total Artificial Hearts and Others. Based on End User, the market is segmented into Hospitals, Cardiac Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Heart Transplant Market
A significant challenge facing the global heart transplant market is the ongoing shortage of donor organs, specifically viable hearts, which restricts the number of transplant procedures that can be performed. This scarcity not only hampers patient access to life-saving transplants but also places enormous pressure on healthcare systems. Additionally, the intricate logistics surrounding organ procurement, preservation, and transportation add another layer of complexity, further complicating the successful execution of heart transplants. These factors create a critical bottleneck in the market, necessitating innovative solutions to enhance organ availability and streamline the processes involved in transplantation.
Restraints in the Global Heart Transplant Market
A significant challenge facing the global heart transplant market is the persistent shortage of donor organs, especially viable hearts, which restricts the number of transplant procedures that can be performed. This scarcity creates a bottleneck in patient access to life-saving surgeries. Additionally, the intricate logistics involved in the procurement, preservation, and transportation of organs pose further complications, adding to the difficulties in effectively managing transplant programs. These factors collectively hinder the overall growth and efficiency of the heart transplant market, as healthcare providers grapple with the delicate balance of supply and demand amidst stringent operational requirements.
Market Trends of the Global Heart Transplant Market
The Global Heart Transplant market is experiencing a notable shift towards advanced technologies that enhance both organ preservation and transplant outcomes. Innovations such as normothermic machine perfusion are improving the viability of donor hearts, while genetic testing is gaining momentum for personalized medicine approaches. Concurrently, regenerative medicine, particularly stem cell therapies, is being explored to reduce rejection risks and improve recovery. Additionally, the rise of telemedicine and remote patient monitoring is transforming post-transplant care, ensuring continuous patient health management. This combination of cutting-edge technology, personalized treatment, and improved post-operative support underscores a dynamic evolution within the heart transplant landscape.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Landscape
- Case Studies
- Technological Advancement
Global Heart Transplant Market Size by Type & CAGR (2026-2033)
- Market Overview
- Ventricular Assist Devices
- Total Artificial Hearts
- Others
Global Heart Transplant Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Cardiac Institutes
- Others
Global Heart Transplant Market Size & CAGR (2026-2033)
- North America (Type, End User)
- US
- Canada
- Europe (Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Optum Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis Pharmaceuticals UK Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mayo Clinic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cleveland Clinic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Massachusetts General Hospital (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corp. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NewYork-Presbyterian Hospital (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cedars-Sinai Medical Center (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Maquet Holding B.V. and Co. KG. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stanford Health Care (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johns Hopkins Hospital (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thoratec Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abiomed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baylor St. Luke's Medical Center (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
